Syneron Medical Ltd. (ELOS) [Rocket]

Overview

Syneron Medical Ltd. (ELOS)

Add to portfolio

1m \| 3m \| 6m \| 1y \| 2y \| 5y \| 10y

Recent News + Filings (All items)

Date Filed	Type	Description
08/01/2017	SC 13D/A	European High-Tech Capital S.A. reports a 0% stake in Syneron Medical Ltd.
07/27/2017	15-12G	Form 15-12G - Securities registration termination [Section 12(g)]:
07/17/2017	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
07/17/2017	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
07/17/2017	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
07/17/2017	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
07/17/2017	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-16	Dec-31-15	Dec-31-14	Dec-31-13	Dec-31-12	Dec-31-11	Dec-31-10	Dec-31-09
Revenues	298.1	277.8	255.8	256.9	263.6	228.3	189.5	54.7
Revenue growth	7.3%	8.6%	-0.5%	-2.5%	15.5%	20.5%	246.3%	-52.4%
Cost of goods sold	142.5	128.9	119.8	126.8	127.2	113.5	98.6	18.9
Gross profit	155.6	149.0	136.0	130.1	136.4	114.8	90.9	35.8
Gross margin	52.2%	53.6%	53.2%	50.6%	51.8%	50.3%	48.0%	65.5%
Sales and marketing	95.9	97.2	80.7	82.4	77.8	69.4	65.9	34.2
Research and development	23.0	25.3	24.6	30.0	29.9	28.3	26.8	13.2
General and administrative	28.5	30.1	28.4	28.4	34.2	33.7	36.1	16.5
EBITA	4.4	6.4	4.8	0.9	0.1	-40.7	-25.2	-24.1
EBITA margin	1.5%	2.3%	1.9%	0.4%	0.0%	-17.8%	-13.3%	-44.0%
Amortization of intangibles	4.3	5.7	5.8	7.0	7.9	8.1	6.9
EBIT	0.0	0.7	-1.0	-6.1	-7.8	-48.7	-32.1	-24.1
EBIT margin	0.0%	0.2%	-0.4%	-2.4%	-2.9%	-21.3%	-16.9%	-44.0%
Pre-tax income	4.0	-6.3	-2.9	-6.1	-6.8	-47.8	-32.4	-21.4
Income taxes	3.8	0.0	2.3	-7.6	-4.5	3.9	-5.1	3.2
Tax rate	95.5%			125.4%	65.8%		15.7%
Net income	0.2	-6.3	-5.2	1.4	-3.3	-52.7	-25.4	-25.7
Net margin	0.1%	-2.3%	-2.0%	0.6%	-1.3%	-23.1%	-13.4%	-46.9%

Diluted EPS	$0.01	($0.17)	($0.14)	$0.04	($0.09)	($1.50)	($0.74)	($0.86)
Shares outstanding (diluted)	34.7	36.4	36.7	36.2	35.5	35.2	34.4	29.9

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.